Novartis to Acquire Regulus Therapeutics for Up to $1.7 Billion
CompanyDeals

Novartis to Acquire Regulus Therapeutics for Up to $1.7 Billion

CSPC's JMT202 Receives FDA IND Approval for Hypertriglyceridemia Trials
CompanyDrug

CSPC’s JMT202 Receives FDA IND Approval for Hypertriglyceridemia Trials

Guilin Sanjin's BC006 Monoclonal Antibody Gains NMPA Approval for IPF Trials
CompanyDrug

Guilin Sanjin’s BC006 Monoclonal Antibody Gains NMPA Approval for IPF Trials

Innovent Biologics Presents Positive IBI302 Results for nAMD at ARVO 2025
CompanyDrug

Innovent Biologics Presents Positive IBI302 Results for nAMD at ARVO 2025

AccurEdit Therapeutics' ART001 Shows Promising Results in ATTR Treatment
CompanyDrug

AccurEdit Therapeutics’ ART001 Shows Promising Results in ATTR Treatment

Novo Nordisk's Once-Daily Wegovy NDA Accepted for FDA Review
CompanyDrug

Novo Nordisk’s Once-Daily Wegovy NDA Accepted for FDA Review

Nanjing Perlove Medical Equipment Files IPO Application in Hong Kong
CompanyDeals

Nanjing Perlove Medical Equipment Files IPO Application in Hong Kong

Sanofi's Opella Becomes Independent Consumer Healthcare Company After CD&R Deal
CompanyDeals

Sanofi’s Opella Becomes Independent Consumer Healthcare Company After CD&R Deal

Johnson & Johnson's Imaavy Gains FDA Approval for Generalized Myasthenia Gravis
CompanyDrug

Johnson & Johnson’s Imaavy Gains FDA Approval for Generalized Myasthenia Gravis

Chengdu Origen Announces First Patient Dosing of KH658 in Wet AMD Trial
CompanyDrug

Chengdu Origen Announces First Patient Dosing of KH658 in Wet AMD Trial

China's 13 Ministries Release Guidance to Optimize Primary Healthcare Institutions
Policy / Regulatory

China’s 13 Ministries Release Guidance to Optimize Primary Healthcare Institutions

AstraZeneca's Breztri Aerosphere Meets Primary Endpoints in Phase III Asthma Trials
CompanyDrug

AstraZeneca’s Breztri Aerosphere Meets Primary Endpoints in Phase III Asthma Trials